The Defense Logistics Agency awarded a single-award indefinite delivery contract to DMS Pharmaceutical Group Inc. to procure pharmaceutical products and medical supplies. Over the period of performance from March 2022 to November 2025, DLA issued firm fixed-price delivery orders against the IDV valued up to $499,999,999 to be fulfilled by DMS Pharmaceutical as the prime contractor. Delivery orders awarded to date procured a range of pharmaceuticals, medical consumables, and vaccine products from DMS Pharmaceutical's facility in Park Ridge, Illinois to support DLA's global supply chain mission. No set-aside provisions were applied. As the leading agency providing logistics support to the Department of Defense, DLA utilizes prime vendor contracts such as this IDV to ensure military treatment facilities and contingency operations have reliable access to essential medicines, thereby maintaining military medical readiness worldwide.
The IDV and associated delivery orders awarded to DMS Pharmaceutical procure pharmaceutical products and medical supplies for distribution via DLA's supply chain network. Delivery orders awarded to date procured pharmaceuticals including antibiotics, steroids, hormonal drugs, vaccines, and other prescription and over-the-counter medications. Medical consumables such as surgical lubricants were also within scope. Delivery orders ranged from a few dollars to several thousand dollars and required fulfillment timeframes from one day to over a year. Performance occurred at DMS Pharmaceutical's Illinois location as the prime vendor, with supplies delivered to DLA distribution centers and customers domestically and abroad as needed to support the agency's medical logistics responsibilities for the Department of Defense.
Generated 1/4/24, 11:09 PM